Erythropoietin (EPO) Affords More Potent Cardioprotection by Activation of Distinct Signaling to Mitochondrial Kinases Compared with Carbamylated EPO
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Erythropoietin (EPO) Affords More Potent Cardioprotection by Activation of Distinct Signaling to Mitochondrial Kinases Compared with Carbamylated EPO
Authors
Keywords
-
Journal
CARDIOVASCULAR DRUGS AND THERAPY
Volume 24, Issue 5-6, Pages 401-408
Publisher
Springer Nature
Online
2010-10-15
DOI
10.1007/s10557-010-6265-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Functional erythropoietin receptor is undetectable in endothelial, cardiac, neuronal, and renal cells
- (2010) A. M. Sinclair et al. BLOOD
- Darbepoetin-mediated cardioprotection after myocardial infarction involves multiple mechanisms independent of erythropoietin receptor-common β-chain heteroreceptor
- (2010) Peter Kanellakis et al. BRITISH JOURNAL OF PHARMACOLOGY
- The mitochondrial permeability transition pore as a target for preconditioning and postconditioning
- (2009) Derek J. Hausenloy et al. BASIC RESEARCH IN CARDIOLOGY
- Regulation and pharmacology of the mitochondrial permeability transition pore
- (2009) D. B. Zorov et al. CARDIOVASCULAR RESEARCH
- GSK-3β, a Therapeutic Target for Cardiomyocyte Protection
- (2009) Tetsuji Miura et al. CIRCULATION JOURNAL
- Role of Glycogen Synthase Kinase-3β in Cardioprotection
- (2009) Magdalena Juhaszova et al. CIRCULATION RESEARCH
- Endoplasmic Reticulum Stress in Diabetic Hearts Abolishes Erythropoietin-Induced Myocardial Protection by Impairment of Phospho–Glycogen Synthase Kinase-3β–Mediated Suppression of Mitochondrial Permeability Transition
- (2009) Takayuki Miki et al. DIABETES
- Carbamylated darbepoetin derivative prevents endothelial progenitor cell damage with no effect on angiogenesis
- (2009) Rafael Ramirez et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Activation of mitochondrial ERK protects cancer cells from death through inhibition of the permeability transition
- (2009) A. Rasola et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Carbamylated erythropoietin protects the myocardium from acute ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism
- (2009) Xuan Xu et al. SURGERY
- Ser9 phosphorylation of mitochondrial GSK-3β is a primary mechanism of cardiomyocyte protection by erythropoietin against oxidant-induced apoptosis
- (2008) Katsuhiko Ohori et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Inhibition of GSK3β by Postconditioning Is Required to Prevent Opening of the Mitochondrial Permeability Transition Pore During Reperfusion
- (2008) Ludovic Gomez et al. CIRCULATION
- Glycogen Synthase Kinase-3 Inactivation Is Not Required for Ischemic Preconditioning or Postconditioning in the Mouse
- (2008) Yasuhiro Nishino et al. CIRCULATION RESEARCH
- Ischemic Postconditioning in Pigs
- (2008) Andreas Skyschally et al. CIRCULATION RESEARCH
- LIMITATION OF INFARCT SIZE BY ERYTHROPOIETIN IS ASSOCIATED WITH TRANSLOCATION OF Akt TO THE MITOCHONDRIA AFTER REPERFUSION
- (2008) Hironori Kobayashi et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Erythropoietin in cardiac disease: New features of an old drug
- (2008) Willem-Peter T. Ruifrok et al. EUROPEAN JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search